Schedule 13G ownership disclosure
GOLDENWELL BIOTECH, INC.
Security class unavailable · CUSIP: 38138N104
Event date: 2021-04-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,000,000
- Percent of class
- 7.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001477932-23-007513
- Form type
- SC 13G
- Filer
- GOLDENWELL BIOTECH, INC.
- CIK
- CIK 1800373
- Filed
- Oct 10, 2023
- Reporting period
- Apr 30, 2021
- Description
- Schedule 13G beneficial ownership